All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
Human papillomavirus (HPV) is a DNA virus from the papillomavirus family that is capable of infecting humans. Like all papillomaviruses, HPVs establish productive infections only in keratinocytes of the skin or mucous membranes. Most HPV infections are subclinical and will cause no physical symptoms; however, in some people subclinical infections will become clinical and may cause benign papillomas (such as warts [verrucae] or squamous cell papilloma), premalignant lesions that will drive to cancers of the cervix, vulva, vagina, penis, oropharynx and anus. In particular, HPV16 and HPV18 are known to cause around 70% of cervical cancer cases.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAR-ZP9443 | Anti-HPV (H18L1-A) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | H18L1-A | Human | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-ZP9444 | Anti-HPV (H18L1-A) h(4-1BB-CD3ζ) CAR, pCDCAR1 | Human | H18L1-A | Human | scFv-4-1BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-ZP9445 | Anti-HPV (6C10) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | 6C10 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-ZP9446 | Anti-HPV (6C10) h(4-1BB-CD3ζ) CAR, pCDCAR1 | Human | 6C10 | Mouse | scFv-4-1BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-ZP9447 | Anti-HPV (13B) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | 13B | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-ZP9448 | Anti-HPV (13B) h(4-1BB-CD3ζ) CAR, pCDCAR1 | Human | 13B | Mouse | scFv-4-1BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-ZP9449 | Anti-HPV (24B) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | 24B | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-ZP9450 | Anti-HPV (24B) h(4-1BB-CD3ζ) CAR, pCDCAR1 | Human | 24B | Mouse | scFv-4-1BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-ZP9451 | Anti-HPV (H11.B2) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | H11.B2 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-ZP9452 | Anti-HPV (H11.B2) h(4-1BB-CD3ζ) CAR, pCDCAR1 | Human | H11.B2 | Mouse | scFv-4-1BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-ZP9453 | Anti-HPV (BSB-66) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | BSB-66 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-ZP9454 | Anti-HPV (BSB-66) h(4-1BB-CD3ζ) CAR, pCDCAR1 | Human | BSB-66 | Mouse | scFv-4-1BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-ZP9455 | Anti-HPV (5G131) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | 5G131 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-ZP9456 | Anti-HPV (5G131) h(4-1BB-CD3ζ) CAR, pCDCAR1 | Human | 5G131 | Mouse | scFv-4-1BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-ZP9457 | Anti-HPV (CB2318) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CB2318 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-ZP9458 | Anti-HPV (CB2318) h(4-1BB-CD3ζ) CAR, pCDCAR1 | Human | CB2318 | Mouse | scFv-4-1BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-ZP9459 | Anti-HPV (SPM257) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | SPM257 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-ZP9462 | Anti-HPV (716-F10) h(4-1BB-CD3ζ) CAR, pCDCAR1 | Human | 716-F10 | Mouse | scFv-4-1BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-ZP9463 | Anti-HPV (716-D1) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | 716-D1 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-ZP9464 | Anti-HPV (716-D1) h(4-1BB-CD3ζ) CAR, pCDCAR1 | Human | 716-D1 | Mouse | scFv-4-1BB-CD3ζ | Lentiviral vector | T cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION